Sakakibara Norikazu, Igarashi Junsuke, Takata Maki, Konishi Ryoji, Kato Yoshihisa, Tsukamoto Ikuko
Faculty of Pharmaceutical Sciences at Kagawa Campus, Tokushima Bunri University.
Department of Cardiovascular Physiology, Faculty of Medicine, Kagawa University.
Chem Pharm Bull (Tokyo). 2017;65(5):504-510. doi: 10.1248/cpb.c17-00056.
Five novel nucleoside analogs with mono or bis-hydroxymethylated cyclopropane rings at the N-position of the 2-chloroadenine moiety (2-chloro-carbocyclic oxetanocin A [COA-Cl] analog) were synthesized and evaluated using human umbilical vein endothelial cells. All the prepared compounds (2a-e) showed good to moderate activity with angiogenic potency. cis-2'-(Hydroxymethyl)cycloprop-1'-yl derivative (2b) at 100 µM had greater angiogenic activity than the other compounds did, with relative tube areas of 2.71±0.45 (mean±standard deviation (S.D.)), which was superior to the potency of COA-Cl (2.30±0.59).
合成了五种新型核苷类似物,其在2-氯腺嘌呤部分的N位具有单或双羟甲基化环丙烷环(2-氯碳环氧杂环丁烷菌素A [COA-Cl]类似物),并用人脐静脉内皮细胞进行了评估。所有制备的化合物(2a - e)均表现出良好至中等的血管生成活性。100µM的顺式-2'-(羟甲基)环丙-1'-基衍生物(2b)具有比其他化合物更强的血管生成活性,相对管面积为2.71±0.45(平均值±标准差(S.D.)),优于COA-Cl的活性(2.30±0.59)。